Literature DB >> 23823177

Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn's disease and ulcerative colitis.

Giorgos Chouliaras1, Ioanna Panayotou, Daphne Margoni, Emilia Mantzou, Panagiota Pervanidou, Yannis Manios, George P Chrousos, Eleftheria Roma.   

Abstract

BACKGROUND: Crohn's disease (CD) and ulcerative colitis (UC) result in metabolic consequences. We assessed circulating leptin and adiponectin concentrations and examined their relations to glucose metabolism in children with CD and UC.
METHODS: Circulating morning fasting concentrations of leptin, adiponectin, glucose, and insulin were measured in 32 children with CD and 18 children with UC. Insulin resistance (IR) and β-cell function were evaluated by the updated homeostatic model assessments (HOMA2-IR and HOMA2-B).
RESULTS: Leptin was positively related to BMI z-scores overall and in the CD and the UC subgroups (P < 0.001). A negative correlation between leptin and disease activity was observed in the entire population (P = 0.034) and in the UC (P = 0.03) group. None of the assessed parameters was related to adiponectin. Fourteen percent of the participants were insulin resistant (15.6% in the CD group and 11.1% in the UC group), significantly more than expected (P < 0.001). Leptin was associated with HOMA2-IR (overall: r = 0.29, P = 0.045). Pathway analysis suggested that, overall, disease activity and BMI significantly affect leptin, which in turn is the only correlate of HOMA2-IR.
CONCLUSION: Disease activity was significantly and inversely related to leptin in children with inflammatory bowel disease (IBD). A significant proportion of the patients had increased IR, which is positively related to circulating leptin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23823177     DOI: 10.1038/pr.2013.114

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

Review 1.  Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews.

Authors:  Nava Morshedzadeh; Mehran Rahimlou; Hamid Asadzadeh Aghdaei; Shabnam Shahrokh; Mohammad Reza Zali; Parvin Mirmiran
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

2.  GLP-1 nanomedicine alleviates gut inflammation.

Authors:  Arivarasu N Anbazhagan; Mentor Thaqi; Shubha Priyamvada; Dulari Jayawardena; Anoop Kumar; Tarunmeet Gujral; Ishita Chatterjee; Edurne Mugarza; Seema Saksena; Hayat Onyuksel; Pradeep K Dudeja
Journal:  Nanomedicine       Date:  2016-08-20       Impact factor: 5.307

3.  Circulating levels of WISP-1 (Wnt1-inducible signaling pathway protein 1) and other selected adipokines in children with inflammatory bowel disease.

Authors:  E Karásková; V Kubickova; M Velganova-Veghova; M Geryk; H Foltenova; D Karasek
Journal:  Physiol Res       Date:  2022-04-11       Impact factor: 2.139

4.  Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?

Authors:  Resul Kahraman; Turan Calhan; Abdurrahman Sahin; Kamil Ozdil; Zuhal Caliskan; Elif Sinem Bireller; Bedia Cakmakoglu
Journal:  Ther Clin Risk Manag       Date:  2017-09-30       Impact factor: 2.423

5.  Plasma ghrelin and leptin in patients with inflammatory bowel disease and its association with nutritional status.

Authors:  Firas A Ghomraoui; Sami T Alotaibi; Meshal A Alharthi; Saeed S Asiri; Majid A Almadi; Othman R Alharbi; Nahla A Azzam; Abdulrahman M Aljebreen; Maria Saeed; Baraa Hajkhder; Waleed Saeed; Mohammad A Alzoghaibi
Journal:  Saudi J Gastroenterol       Date:  2017 May-Jun       Impact factor: 2.485

Review 6.  Adipokines and the role of visceral adipose tissue in inflammatory bowel disease.

Authors:  Thomas Karrasch; Andreas Schaeffler
Journal:  Ann Gastroenterol       Date:  2016-09-06

Review 7.  The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease.

Authors:  Piotr Eder; Maciej Adler; Agnieszka Dobrowolska; Julian Kamhieh-Milz; Janusz Witowski
Journal:  Cells       Date:  2019-06-21       Impact factor: 6.600

Review 8.  Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases.

Authors:  Jan Bilski; Agnieszka Mazur-Bialy; Dagmara Wojcik; Marcin Surmiak; Marcin Magierowski; Zbigniew Sliwowski; Robert Pajdo; Slawomir Kwiecien; Aleksandra Danielak; Agata Ptak-Belowska; Thomas Brzozowski
Journal:  Biomolecules       Date:  2019-11-26

Review 9.  Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1.

Authors:  Tamara Zietek; Eva Rath
Journal:  Front Immunol       Date:  2016-04-22       Impact factor: 7.561

10.  Adiponectin and adiponectin receptor 1 overexpression enhance inflammatory bowel disease.

Authors:  Yu-Ju Peng; Tang-Long Shen; Yu-Shan Chen; Harry John Mersmann; Bing-Hsien Liu; Shih-Torng Ding
Journal:  J Biomed Sci       Date:  2018-03-14       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.